Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MAGiC™ Ablation Catheter in Congenital Heart Disease Arrhythmias Post-Approval Study

NCT07812818 is registered in ClinicalTrials.gov with Stereotaxis as lead sponsor.

NCT NCT07812818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07812818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MAGiC™ Ablation Catheter in Congenital Heart Disease Arrhythmias Post-Approval Study
Lead sponsor
Stereotaxis
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2029
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease (chd), supraventricular tachycardia (svt)